Prelude and Loyal: Collaborating to Extend Canine Lifespans
The growing rates of canine ownership and the rising demand for solutions to improve the health of dogs have highlighted the need for innovation within the animal health industry. This partnership was established with the core mission of providing an eClinical technology partner to advance the development of groundbreaking solutions that align with Loyal's commitment to extending the lives of dogs.
Through this partnership, Loyal will leverage Prelude's suite of data management products to enhance their research endeavors, ultimately benefiting the longevity and well-being of dogs. Prelude's EDC allows for seamless data collection, monitoring, and analysis, enabling Loyal to gather crucial insights. Additionally, Prelude's mobile ePRO app allows pet owners to input data directly into Prelude's EDC, facilitating owner feedback in real time and improving overall study compliance.
With access to Prelude's animal health data management products, Loyal can streamline their trials and enhance the efficiency of their clinical studies. Prelude's flexible EDC system and mobile ePRO app will serve as invaluable tools in supporting Loyal's mission to extend the lives and improve the health of dogs.
"I'm excited to join forces with Loyal," says Prelude CEO
"Prelude's products allow us to build and execute customized, veterinary clinic and subject-centric studies that deliver fast, accurate data," says
About Prelude
Prelude is a life science software company looking to raise the bar on the clinical research experience, thus making the world safer and healthier by accelerating new product development of life-saving medicine and devices.
Founded in 2003, Prelude's founders created a new type of electronic data capture (EDC) system – that is, with the end-user in mind while still being able to withstand the most extreme scrutiny for data, accuracy, and speed. Today, Prelude offers mobile applications to support modern data collection.
Prelude's ePRO mobile app enables subjects participating in a clinical trial to input data directly into Prelude's EDC system, enabling real-time patient updates at any time from any place.
Prelude prioritizes providing comprehensive support to teams who choose to entrust their studies to them with the goal of making the study building to closeout process as simple and straightforward as possible so that their clients can focus on what matters – their research. For more information, please visit www.PreludeEDC.com.
About Loyal
Founded in
They are developing drugs intended to help dogs live longer, healthier lives by targeting biological mechanisms associated with aging. These products are prescribed by veterinarians and aim to prevent and delay the onset of many age-related diseases. For more information, please visit www.loyalfordogs.com.
Media Contact
(512) 476-5100
View original content to download multimedia:https://www.prnewswire.com/news-releases/prelude-and-loyal-collaborating-to-extend-canine-lifespans-302122387.html
SOURCE Prelude
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beyond the Screen: Hero Esports CEO Highlights Role of Esports in Creating Shared Urban Experiences at LEAP East 2026
- TotalEnergies SE: Disclosure of Transactions in Own Shares
- PointsKash Completes Strategic Acquisition of ChainBytes Software Assets and Adds Founder Eric Grill to Accelerate AI-Powered Fintech Platform
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share